CSS
MRVI icon

Cubist Systematic Strategies’s Maravai LifeSciences MRVI Stock Holding History

Cubist Systematic Strategies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-284,146
Closed -$2.03M – 3313
2024
Q2 		$2.03M Sell
284,146
-75,957
-21% -$656K 0.01% 1324
2024
Q1 		$3.12M Buy
360,103
+247,707
+220% +$1.68M 0.02% 1299
2023
Q4 		$736K Buy
+112,396
New +$726K ﹤0.01% 2289
2023
Q3 		– Sell
-6,618
Closed -$82.3K – 3722
2023
Q2 		$82.3K Sell
6,618
-163,371
-96% -$2.21M ﹤0.01% 3032
2023
Q1 		$2.38M Sell
169,989
-126,750
-43% -$1.82M 0.01% 1534
2022
Q4 		$4.25M Buy
296,739
+294,199
+11,583% +$4.63M 0.02% 1162
2022
Q3 		$65K Sell
2,540
-202,385
-99% -$5.08M ﹤0.01% 4094
2022
Q2 		$5.82M Buy
204,925
+21,187
+12% +$671K 0.04% 852
2022
Q1 		$6.48M Buy
183,738
+99,047
+117% +$3.32M 0.05% 535
2021
Q4 		$3.55M Sell
84,691
-36,267
-30% -$1.47M 0.03% 891
2021
Q3 		$5.94M Buy
120,958
+25,662
+27% +$1.25M 0.07% 382
2021
Q2 		$3.98M Buy
95,296
+31,902
+50% +$1.24M 0.04% 670
2021
Q1 		$2.26M Sell
63,394
-14,395
-19% -$477K 0.03% 943
2020
Q4 		$2.18M Buy
+77,789
New +$2.17M 0.03% 889

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cubist Systematic Strategies's MRVI Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 284,146 shares — an estimated $2.03M sold.

Cubist Systematic Strategies first reported a position in MRVI in Q4 2020 and held it in 14 quarters. The position peaked at $6.48M in Q1 2022. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 284,146 Maravai LifeSciences shares in Q3 2024, an estimated $2.03M.
  • Cubist Systematic Strategies first reported a position in Maravai LifeSciences in Q4 2020 and held it in 14 quarters.
  • Cubist Systematic Strategies's Maravai LifeSciences position peaked at $6.48M in Q1 2022.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.